cobolimab
gsk
['thanks', 'cobolimab', 'congrat']
gerald falchook, md (scri denver ddu director) in #asco22 dev ther orals: presenting cobolimab - tim3 ab ph i: early safety and response data (io naive)
- outstanding talk! congratulations to the team and thanks to all who participated! 
Chief Scientific Officer, Sarah Cannon Research Institute; Thoracic Medical Oncology, Tennessee Oncology